清肺通络汤治疗卒中后多重耐药菌感染肺炎的临床价值分析

Clinical efficacy of the Qingfei Tongluo decoction on pneumonia with multidrug-resistant bacteria after stroke

目的:探究清肺通络汤对于卒中后多重耐药菌感染肺炎的临床治疗效果。方法:在于我院进行治疗的脑卒中后多重耐药菌感染肺炎患者中择取120 例,将其随机分为常规组与研究组,两组各有患者60 例。常规组使用常规抗感染药物进行治疗,研究组在常规抗感染治疗的基础上增加清肺通络汤进行治疗,观察并对比两组方案的治疗效果以及患者治疗后的各项肺功能指标。结果:研究组患者的一秒用力呼气量(Forced Expiratory Volume in 1 Second, FEV1)、用力肺活量(Forced Vital Capacity,FVC)、呼气峰流速(Peak Expiratory Flow, PEF)指数均优于常规组;研究组患者的美国国立卫生院卒中量表(National Institutesof Health Stroke Scale,NIHSS)评分与临床肺部感染评分(Clinical Pulmonary Infection Score,CPIS)评分均低于常规组;研究组总有效率(95.00%)高于常规组(78.33%),差异存在统计学意义(P < 0.05)。结论:对脑卒中后多重耐药菌感染肺炎患者应用清肺通络汤进行治疗的效果显著,可有效缓解患者的临床症状,促进肺功能的恢复,具有较好的临床应用效果,值得广泛推广。

Objective: To explore the effect of the Qingfei Tongluo decoction (清肺通络汤) on pneumonia with multidrug-resistant bacteria after stroke. Methods: 120 patients were randomly divided into the conventional group and the study group, 60 patients in each group. The conventional group was treated with conventional anti-infective drugs. The research group was given the Qingfei Tongluo decoction more. Results: FEV1, FVC and PEF in the research group were better. NIHSS and CPIS scores in the research group were lower. The total efficiency was 95.00% in the research group, better than 78.33% in the conventional group. Conclusion: The Qingfei Tongluo decoction on pneumonia with multidrug-resistant bacteria after stroke was effective, by improving clinical symptoms, and is worthy of promotion.